UBS Group’s Oncolytics Biotech ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.1K Sell
20,796
-102
-0.5% -$79 ﹤0.01% 7270
2025
Q1
$11.5K Hold
20,898
﹤0.01% 7238
2024
Q4
$19.1K Sell
20,898
-2,038
-9% -$1.86K ﹤0.01% 6673
2024
Q3
$20K Buy
22,936
+17,333
+309% +$15.1K ﹤0.01% 6167
2024
Q2
$5.55K Buy
5,603
+4,439
+381% +$4.4K ﹤0.01% 6822
2024
Q1
$1.23K Sell
1,164
-3,535
-75% -$3.75K ﹤0.01% 7012
2023
Q4
$6.34K Sell
4,699
-2,966
-39% -$4K ﹤0.01% 6501
2023
Q3
$16.7K Sell
7,665
-5,789
-43% -$12.6K ﹤0.01% 5759
2023
Q2
$35K Buy
13,454
+4,304
+47% +$11.2K ﹤0.01% 5586
2023
Q1
$11K Buy
9,150
+1,485
+19% +$1.78K ﹤0.01% 6445
2022
Q4
$12.5K Hold
7,665
﹤0.01% 7074
2022
Q3
$9K Sell
7,665
-2,558
-25% -$3K ﹤0.01% 7486
2022
Q2
$11K Buy
10,223
+10,058
+6,096% +$10.8K ﹤0.01% 6790
2022
Q1
$0 Sell
165
-3,140
-95% ﹤0.01% 9471
2021
Q4
$4K Sell
3,305
-23,485
-88% -$28.4K ﹤0.01% 8412
2021
Q3
$56K Buy
26,790
+6,101
+29% +$12.8K ﹤0.01% 5154
2021
Q2
$57K Buy
20,689
+18,577
+880% +$51.2K ﹤0.01% 5258
2021
Q1
$8K Buy
2,112
+1,948
+1,188% +$7.38K ﹤0.01% 7058
2020
Q4
$0 Hold
164
﹤0.01% 7538
2020
Q3
$0 Hold
164
﹤0.01% 7292
2020
Q2
$0 Sell
164
-580
-78% ﹤0.01% 7240
2020
Q1
$1K Sell
744
-2,256
-75% -$3.03K ﹤0.01% 6857
2019
Q4
$14K Buy
3,000
+2,256
+303% +$10.5K ﹤0.01% 6020
2019
Q3
$0 Hold
744
﹤0.01% 7109
2019
Q2
$1K Buy
744
+52
+8% +$70 ﹤0.01% 6847
2019
Q1
$1K Sell
692
-120
-15% -$173 ﹤0.01% 6715
2018
Q4
$1K Sell
812
-5,241
-87% -$6.45K ﹤0.01% 6971
2018
Q3
$24K Buy
6,053
+1,762
+41% +$6.99K ﹤0.01% 5787
2018
Q2
$24K Buy
+4,291
New +$24K ﹤0.01% 5654